Barrington Research reiterated their outperform rating on shares of Healthways Inc. (NASDAQ:HWAY) in a report published on Thursday. They currently have a $30.00 price objective on the stock, up from their previous price objective of $29.00.
Several other research analysts have also recently commented on the company. Zacks Investment Research raised Healthways from a hold rating to a buy rating and set a $29.00 price target for the company in a research report on Wednesday, September 21st. Barclays PLC upgraded Healthways from an underweight rating to an equal weight rating and upped their price objective for the company from $12.00 to $27.00 in a research note on Monday, August 22nd. Jefferies Group set a $26.00 price objective on Healthways and gave the company a hold rating in a research note on Thursday, August 18th. Oppenheimer Holdings Inc. upgraded Healthways to an outperform rating and set a $27.00 price objective on the stock in a research note on Sunday, August 14th. Finally, Piper Jaffray Cos. upped their price objective on Healthways from $15.00 to $25.50 and gave the company an overweight rating in a research note on Wednesday, August 10th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The company presently has an average rating of Buy and a consensus target price of $26.50.
Shares of Healthways (NASDAQ:HWAY) opened at 25.25 on Thursday. Healthways has a 52 week low of $9.18 and a 52 week high of $27.30. The firm’s market cap is $927.63 million. The company has a 50-day moving average price of $25.35 and a 200 day moving average price of $16.68.
Healthways (NASDAQ:HWAY) last issued its quarterly earnings results on Tuesday, August 9th. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.01 by $0.53. Healthways had a positive return on equity of 8.83% and a negative net margin of 31.32%. The firm earned $125 million during the quarter, compared to analysts’ expectations of $186.88 million. During the same period in the prior year, the firm posted $0.11 earnings per share. The business’s quarterly revenue was up 10.2% compared to the same quarter last year. Analysts expect that Healthways will post $2.11 EPS for the current fiscal year.
In other news, Director Mary Jane England sold 3,816 shares of the stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $24.78, for a total transaction of $94,560.48. Following the transaction, the director now owns 39,068 shares in the company, valued at $968,105.04. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 14.01% of the company’s stock.
A number of institutional investors have recently bought and sold shares of the company. Acrospire Investment Management LLC raised its position in Healthways by 80.9% in the second quarter. Acrospire Investment Management LLC now owns 9,612 shares of the company’s stock worth $111,000 after buying an additional 4,300 shares during the period. Quantitative Systematic Strategies LLC bought a new position in Healthways during the second quarter worth approximately $118,000. Profund Advisors LLC raised its position in Healthways by 4.5% in the second quarter. Profund Advisors LLC now owns 10,668 shares of the company’s stock worth $123,000 after buying an additional 456 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA raised its position in Healthways by 7.6% in the second quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 11,685 shares of the company’s stock worth $135,000 after buying an additional 825 shares during the period. Finally, KBC Group NV bought a new position in Healthways during the second quarter worth approximately $147,000. Hedge funds and other institutional investors own 92.60% of the company’s stock.
Healthways Company Profile
Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.
Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.